(UPDATED) Over the long term, patients with asymptomatic severe carotid stenosis who are already on good medical therapy fare comparably well whether the artery is opened with stenting or surgery, ...

CREST-2 may end routine CEA for asymptomatic carotid stenosis, but its message is nuanced, raising new questions about ...

HONOLULU, HI—Results of carotid revascularization with either surgery or stenting stand up well over the long term, with very low rates of stroke through up to a decade of follow-up, new data from the ...

HONOLULU — Carotid stenting and surgery provide similar long-term protection from stroke for symptomatic patients with severe carotid stenosis followed for up to a decade in a pooled patient-level ...

ABBOTT PARK, Ill., May 6, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) approved the RX ACCULINK® Carotid Stent System for the treatment of ...

Carotid endarterectomy (CEA) is considered the gold standard for treatment of stenosis, but carotid artery stenting (CAS) is a less invasive procedure that offers a promising alternative. Short-term ...

After reviewing outcomes from thousands of cases, researchers at Johns Hopkins report that patients with blocked neck arteries who undergo carotid stenting to prop open the narrowed blood vessels fare ...

Sophia Antipolis, France – 29 Aug 2021: Carotid artery surgery and stenting have comparable long-term effects on fatal or disabling stroke in asymptomatic patients with severe carotid artery stenosis.

In the ACST-2 trial, non-procedural fatal or disabling stroke occurred in 2.5% of patients in both groups -- those assigned to carotid stenting and those who underwent carotid endarterectomy, for a ...

Each year, more than 100,000 patients who have experienced a stroke or a transient ischemic attack (TIA), also known as a “mini-stroke,” undergo a carotid artery stenting procedure to increase blood ...

Almost 800,000 Americans suffer a stroke every year. Strokes are the third most common cause of death in the US, and are frequently disabling to those who survive. These sobering numbers are despite ...

When FDA approved the first carotid stent, in August 2004, many industry analysts suggested that the market for such devices could reach $1 billion by 2010. Since that time, however, forecasts have ...